Article Versions Notes

Contreras Vite JA, Tiffinger A, Théroux L, Morin N, Auger-Messier M, Boudreault P-L, Sarret P, Lesur O, Dumaine R. A Metabolically Stable Apelin-13 Analog Acting as a Potent I_To Potassium Current Blocker with Potential Benefits for Brugada Syndrome. International Journal of Molecular Sciences. 2025; 26(6):2735. https://doi.org/10.3390/ijms26062735

Contreras Vite, Juan Antonio, Alexandria Tiffinger, Léa Théroux, Nathalie Morin, Mannix Auger-Messier, Pierre-Luc Boudreault, Philippe Sarret, Olivier Lesur, and Robert Dumaine. 2025. "A Metabolically Stable Apelin-13 Analog Acting as a Potent I_To Potassium Current Blocker with Potential Benefits for Brugada Syndrome" International Journal of Molecular Sciences 26, no. 6: 2735. https://doi.org/10.3390/ijms26062735

Contreras Vite, J. A., Tiffinger, A., Théroux, L., Morin, N., Auger-Messier, M., Boudreault, P.-L., Sarret, P., Lesur, O., & Dumaine, R. (2025). A Metabolically Stable Apelin-13 Analog Acting as a Potent I_To Potassium Current Blocker with Potential Benefits for Brugada Syndrome. International Journal of Molecular Sciences, 26(6), 2735. https://doi.org/10.3390/ijms26062735